CYLD cutaneous syndrome
| CYLD cutaneous syndrome | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Skin tumors, cylindromas, trichoepitheliomas, spiradenomas |
| Complications | Malignant transformation |
| Onset | Childhood or early adulthood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the CYLD gene |
| Risks | Family history |
| Diagnosis | Clinical examination, genetic testing |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Surgical removal, laser therapy |
| Medication | N/A |
| Prognosis | Variable, depending on tumor burden and management |
| Frequency | N/A |
| Deaths | N/A |
CYLD cutaneous syndrome is a rare genetic disorder characterized by the development of multiple skin tumors, primarily cylindromas, trichoepitheliomas, and spiradenomas. These tumors are generally benign but can cause significant cosmetic and functional issues. In some cases, there is a risk of malignant transformation.
Genetics
CYLD cutaneous syndrome is caused by mutations in the CYLD gene, which is located on chromosome 16q12.1. The CYLD gene encodes a protein that acts as a tumor suppressor by regulating cell proliferation and apoptosis. Mutations in this gene lead to uncontrolled cell growth, resulting in the formation of skin tumors.
Clinical Features
Patients with CYLD cutaneous syndrome typically present with multiple skin lesions that appear in childhood or early adulthood. The most common types of tumors include:
- Cylindromas: Dome-shaped nodules that often occur on the scalp and can coalesce to form a "turban tumor."
- Trichoepitheliomas: Small, flesh-colored papules that usually appear on the face.
- Spiradenomas: Painful nodules that can occur anywhere on the body.
Diagnosis
Diagnosis of CYLD cutaneous syndrome is based on clinical examination and family history. Genetic testing can confirm the presence of mutations in the CYLD gene. Histopathological examination of the tumors can also aid in diagnosis.
Management
Management of CYLD cutaneous syndrome involves regular monitoring and surgical removal of symptomatic or cosmetically concerning tumors. Laser therapy may be used for smaller lesions. In cases where there is a risk of malignant transformation, more aggressive treatment may be necessary.
Prognosis
The prognosis for individuals with CYLD cutaneous syndrome varies. While the tumors are generally benign, they can cause significant cosmetic and psychological distress. Regular follow-up and management are essential to prevent complications.
Also see
| Genetics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
* Category
|
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


